Skip to main content

Table 1 Baseline characteristics of 6543 women included in nested case-control analysis

From: Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype

Characteristic

Casesa (n = 1823)

Controlsa (n = 4720)

Age at diagnosis, years (median, IQR)

60 (52–69)

 

Age at mammogram, years (median, IQR)

56 (48–65)

55 (48–65)

Race/ethnicity, No. (%)

 Caucasian

1330 (73.0)

3365 (71.3)

 Asian

301 (16.5)

844 (17.9)

 Hispanic/Latina

69 (3.8)

143 (3.0)

 African-American

69 (3.8)

199 (4.2)

 Multiracial

34 (1.8)

121 (2.6)

 Other (not falling in categories above)

20 (1.1)

48 (1.0)

BMI, kg/m2 (median, IQR)

24.8 (22.0–28.9)

24.2 (21.6–27.6)

Menopausal statusa

 Premenopausal

610 (33.5%)

1507 (31.9%)

 Postmenopausal, estrogen use

140 (7.7%)

435 (9.2%)

 Postmenopausal, estrogen + progestin use

339 (18.6%)

689 (14.6%)

 Postmenopausal, no HT use

734 (40.3%)

2089 (44.3%)

Positive family history of breast cancer, No. (%)

404 (22.2%)

712 (15.1%)

Percent density (median, IQR)

31.8 (16.9–48.4)

24.7 (12.0–41.0)

  1. Abbreviations: BMI body mass index, HT hormone therapy, IQR interquartile range (25th, 75th percentile)
  2. aControls and cases were matched on age, menopausal status at the time of index mammogram, and year of examination